Latest Stock Market News

Mankind Pharma Q3: Domestic revenue grew 20% YoY to Rs 2,400 crore, while exports more than doubled to Rs 207 crore. The strong domestic revenue was led by robust growth in the chronic portfolio, recovery in anti-infectives and strong growth in modern trade and hospital sales.

Domestic brokerage JM Financial believes BHEL, Alkem, and NMDC, among others, have a high probability of inclusion in the index.

As we approach the Interim Budget 2024, the crypto industry anticipates with earnestness that the government will address the prevalent challenges, signalling a critical juncture for the sector.

​Adani Cement-owned Ambuja Cements’ operating margins surged to their highest level in 10 quarters in Oct-Dec as the company managed to significantly bring down its costs compared to the previous year.

During the first nine months of FY24, the company achieved the highest-ever customer collections, totaling Rs 2,515 crore, reflecting an enhancement in operating efficiencies. Cash flow from operations for 9M FY24 stood at Rs 2,826 crore, reflecting a notable increase of 35% for the same period in 9M FY23. Additionally, the operating surplus for 9M FY24 surged to Rs 965 crore, marking a substantial 101% rise from the same period in FY23. The company’s current cash balance stands at Rs 822 crore.

​Sun Pharma on Wednesday reported a 16.5% year-on-year (YoY) jump in net profit to Rs 2524 crore in Q3FY24 led by broad-based growth, including higher sales of global specialty products.

The Nifty Realty index was trading 0.92 per cent up at 844.8.

The trend may continue to be volatile on Thursday, especially as the Interim Budget will be delivered. Support on the lower end is situated at 21,500, while a decisive move above 21,750 might trigger a rally towards 22,100 and beyond.

Earnings before interest, taxes, depreciation and amortization or EBITDA surged nearly 17% YoY to Rs 247 crore, and operating margins improved 120 basis points to 15.9%.

The initial public offer (IPO) of IT solutions company Rashi Peripherals will open for subscription on February 7 and close on February 9. The allocation to anchor investors will be done a day ahead of the issue opening on February 6. The company had filed draft papers for its IPO last year.